UK and Ireland dates
USA and Canada dates
Australia and NZ dates
Rest Of World dates
Featured Testimonials
THOR on Facebook
THOR on Twitter
THOR on LinkedIn
THOR on Instagram
THOR on YouTubeCategories
Essays
Links
Category Archives: James in Action
James Carroll’s Congress speech on ending opioid use with Photobiomodulation
A hundred million adults in the United States are affected by chronic pain and $600 billion a year is spent on health care, direct health care costs and lost productivity because of pain.
49,000 people died from opioids in 2017, 19,000 of which were from prescribed opioids for pain relief.
We believe that Photobiomodulation therapy can help reduce the prescribing of opioid medication for pain relief and we wish to draw attention to the Congress and health care policymakers, NIH and CMS, about this potentially valuable tool.
Learn more at CongressPBM.com
Watch the Congressional Briefing Highlight Video
Read James Carroll’s Speech to Congress on citizenoversight.blogspot.com
Posted in Industry, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week
on James Carroll’s Congress speech on ending opioid use with Photobiomodulation
Dr. Mercola Interviews James Carroll on the Benefits of Photobiomodulation
Amazing interview with natural health expert and Mercola.com founder Dr. Joseph Mercola hearing from expert James Carroll on the benefits of photobiomodulation, and what the research says about this form of therapy.
Short overview version: 2:47 minutes
Full interview Podcast version: 45:11 minutes
Posted in Interviews, James in Action, Testimonials, Video of the Week
on Dr. Mercola Interviews James Carroll on the Benefits of Photobiomodulation
James Carroll SPIE 2016 interview
The LLLT / PBM world according to James Carroll, CEO of THORLaser
Posted in Industry, Interviews, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week
on James Carroll SPIE 2016 interview
THOR LLLT presentation at United Nations – Global Health Impact Forum
This 15 minute video starts with an overview of Photobiomodulation and low level light therapy. Later in the presentation James introduces the Lumithera treatment for Dry Age related Macular Degeneration (AMD).